Compare LYFT Inc (LYFT) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Sanofi SA — how do they compare? LYFT Inc trades at $17.56 (market cap $6.64B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 15.7× LYFT Inc's market cap, and Sanofi SA pays a 5.55% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| LYFT | SNY | |
|---|---|---|
Market Cap | $6.64B | $104.30B |
Sector | Industrials | Health |
52-Week High | $24.57 | $52.34 |
52-Week Low | $12.65 | $41.33 |
Enterprise Value | $6.11B | $124.19B |
Dividend Yield | — | 5.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $17.26, down 1.15% today, with strong technical momentum showing bullish moving averages but overbought RSI signals. The company demonstrates remarkable fundamental improvement with 2025 revenue reaching $6.32B and net income surging to $2.84B, achieving a 45% profit margin. Recent Q2 2026 results showed revenue growth of 16.1% with record active riders exceeding 30 million, though earnings slightly missed estimates amid higher costs.
Lyft presents a compelling turnaround story with accelerating profitability and market share gains against Uber, supported by expanding robotaxi partnerships and international growth. However, elevated valuation multiples, competitive pressures, and ongoing legal scrutiny create headwinds. With analyst consensus at $19.17 representing 11% upside potential, the stock offers growth exposure but requires monitoring of execution risks and expense management.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
